Wen-Yang Hu - Search Results

Year	Number of Results
2002	4
2003	2
2004	2
2005	2
2006	3
2007	4
2008	1
2009	1
2011	3
2012	1
2013	1
2014	1
2015	2
2017	3
2018	3
2019	4
2020	1
2021	5
2022	3
2023	2
2024	0

1

Lymphangiogenesis Guidance Mechanisms and Therapeutic Implications in Pathological States of the Cornea.

Patnam M, Dommaraju SR, Masood F, Herbst P, Chang JH, Hu WY, Rosenblatt MI, Azar DT. Patnam M, et al. Among authors: hu wy. Cells. 2023 Jan 14;12(2):319. doi: 10.3390/cells12020319. Cells. 2023. PMID: 36672254 Free PMC article. Review.

2

Therapeutic Strategies for Restoring Perturbed Corneal Epithelial Homeostasis in Limbal Stem Cell Deficiency: Current Trends and Future Directions.

Masood F, Chang JH, Akbar A, Song A, Hu WY, Azar DT, Rosenblatt MI. Masood F, et al. Among authors: hu wy. Cells. 2022 Oct 16;11(20):3247. doi: 10.3390/cells11203247. Cells. 2022. PMID: 36291115 Free PMC article. Review.

3

Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.

Hu WY, Shi GB, Hu DP, Nelles JL, Prins GS. Hu WY, et al. Mol Cell Endocrinol. 2012 May 6;354(1-2):63-73. doi: 10.1016/j.mce.2011.08.032. Epub 2011 Sep 5. Mol Cell Endocrinol. 2012. PMID: 21914459 Free PMC article. Review.

4

Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures.

Hu WY, Hu DP, Xie L, Birch LA, Prins GS. Hu WY, et al. J Vis Exp. 2019 Dec 13;(154). doi: 10.3791/60357. J Vis Exp. 2019. PMID: 31885380

5

Per- and polyfluoroalkyl substances target and alter human prostate stem-progenitor cells.

Hu WY, Lu R, Hu DP, Imir OB, Zuo Q, Moline D, Afradiasbagharani P, Liu L, Lowe S, Birch L, Griend DJV, Madak-Erdogan Z, Prins GS. Hu WY, et al. Biochem Pharmacol. 2022 Mar;197:114902. doi: 10.1016/j.bcp.2021.114902. Epub 2021 Dec 27. Biochem Pharmacol. 2022. PMID: 34968493 Free PMC article.

6

Estrogen action and prostate cancer.

Nelles JL, Hu WY, Prins GS. Nelles JL, et al. Among authors: hu wy. Expert Rev Endocrinol Metab. 2011 May;6(3):437-451. doi: 10.1586/eem.11.20. Expert Rev Endocrinol Metab. 2011. PMID: 21765856 Free PMC article.

7

Targeting prostate cancer cells with enzalutamide-HDAC inhibitor hybrid drug 2-75.

Hu WY, Xu L, Chen B, Ou S, Muzzarelli KM, Hu DP, Li Y, Yang Z, Vander Griend DJ, Prins GS, Qin Z. Hu WY, et al. Prostate. 2019 Jul;79(10):1166-1179. doi: 10.1002/pros.23832. Epub 2019 May 28. Prostate. 2019. PMID: 31135075

8

The role of WNT10B in normal prostate gland development and prostate cancer.

Madueke I, Hu WY, Hu D, Swanson SM, Vander Griend D, Abern M, Prins GS. Madueke I, et al. Among authors: hu wy. Prostate. 2019 Oct;79(14):1692-1704. doi: 10.1002/pros.23894. Epub 2019 Aug 21. Prostate. 2019. PMID: 31433503 Free PMC article.

9

Per- and Polyfluoroalkyl Substance Exposure Combined with High-Fat Diet Supports Prostate Cancer Progression.

Imir OB, Kaminsky AZ, Zuo QY, Liu YJ, Singh R, Spinella MJ, Irudayaraj J, Hu WY, Prins GS, Madak Erdogan Z. Imir OB, et al. Among authors: hu wy. Nutrients. 2021 Oct 30;13(11):3902. doi: 10.3390/nu13113902. Nutrients. 2021. PMID: 34836157 Free PMC article.

10

Keratin Profiling by Single-Cell RNA-Sequencing Identifies Human Prostate Stem Cell Lineage Hierarchy and Cancer Stem-Like Cells.

Hu WY, Hu DP, Xie L, Nonn L, Lu R, Abern M, Shioda T, Prins GS. Hu WY, et al. Int J Mol Sci. 2021 Jul 28;22(15):8109. doi: 10.3390/ijms22158109. Int J Mol Sci. 2021. PMID: 34360875 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

45 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year